BioCryst Pharmaceuticals, Inc. (BCRX) Presents at Jefferies London Healthcare Conference 2025 Transcript

The provided text contains only website boilerplate, navigation instructions, and technical notices and includes no substantive financial news, company results, macro data, or policy developments. There are no figures, events, or market-moving details to inform investment decisions.

Analysis

Market structure is favoring liquidity providers and carry strategies over directional alpha right now; bid/offer compression and muted headline flow increase the profitability of time-decay strategies and delta-neutral market-making. Winners: large-cap, high-liquidity ETFs (SPY, QQQ) and repo-funded leveraged strategies; losers: small-cap illiquid names (IWM constituents) and low-float microcaps that suffer when passive flows dominate. Cross-asset: expect limited immediate movement in 10y yields and FX absent macro prints, reducing hedging costs but leaving convexity risk in options markets.

Risk assessment centers on tail shocks from macro prints or geopolitical events that can rapidly repricing crowded short-vol positions; low-probability events to watch include a 30-50bp one-day move in 10y yields or a >4% gap in SPY. Time horizons: days—volatility compression favors premium sellers; weeks—earnings and CPI can flip direction; quarters—fundamentals reassert themselves. Hidden dependencies include dealer balance-sheet capacity, prime-broker funding windows, and options gamma exposure concentrated in near-term expiries.

Trade implications: prioritize defined-risk short-vol trades (30-day iron condors on SPY/QQQ with wings at ±3–4%) and modest relative-value bets (overweight XLK, underweight IWM) to exploit liquidity premia; size 1–3% notional per trade. Use TLT and GLD as tactical hedges if 10y yield moves >20bp or gold rallies >2% in 3 sessions. Establish clear stop thresholds (VIX >20 or SPY move >4%) to protect against gap risk.

Contrarian angles: consensus complacency on volatility is likely underpriced—selling naked premium is hazardous without strict size limits; historical parallels (late-2018 quick vol spikes) show rapid deleveraging when information flow resumes. Mispricings: implied vol 30–60 days out often underestimates realized on macro days—favor structures that cap downside and let theta accrue. Unintended consequence: crowded carry trades amplify moves if dealer hedges reverse, so cap exposure at firm-wide desk limits.

Key Decisions for Investors

• Establish a 2% notional position selling 30-day iron condors on SPY with short strikes ~±3% from spot and long wings ~±5%, size per trade ≤2% NAV and unwind if VIX >20 or SPY gaps >4% intraday.
• Allocate 3% overweight to XLK (or 1–2 large-cap techs: AAPL, MSFT) and reduce IWM exposure by 50% relative to benchmark for 4–8 weeks to capture liquidity and dispersion advantages; rebalance if IWM outperforms SPY by >5% in 30 days.
• Deploy a 1–2% tactical hedge in TLT (long) if 10‑yr yield drops >20bp within a 7‑day window, or buy 1–2% GLD if gold rises >2% over 3 trading days, to protect portfolio convexity over the next 1–3 months.
• Initiate a 1% long/1% short pair: long QQQ and short ARKK-sized ETFs to express quality growth vs speculative basket divergence for 2–3 months, close if QQQ underperforms ARKK by >6% over 30 days.